Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies

Title
Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies
Authors
Keywords
BiTE, Immunotherapy, NHL, ALL, AML, Blinatumomab, AMG 330
Journal
MOLECULAR IMMUNOLOGY
Volume 67, Issue 2, Pages 58-66
Publisher
Elsevier BV
Online
2015-04-13
DOI
10.1016/j.molimm.2015.02.033

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started